(Q33987476)

30 July 2017

title

Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy (English)

1 reference

attention deficit hyperactivity disorder

30 July 2017

1 reference

0 references

author

Stephen Faraone

6

1 reference

30 July 2017

13

Alcy Torres

1 reference

30 July 2017

15

Joseph Biederman

1 reference

30 July 2017

5

Olivia Hsin

1 reference

30 July 2017

9

Christine Mrakotsky

1 reference

30 July 2017

author name string

Joseph Gonzalez-Heydrich

1

1 reference

30 July 2017

Jane Whitney

2

1 reference

30 July 2017

Deborah Waber

3

1 reference

30 July 2017

Peter Forbes

4

1 reference

30 July 2017

Alice Dodds

7

1 reference

30 July 2017

Sneha Rao

8

1 reference

30 July 2017

Carlene Macmillan

10

1 reference

30 July 2017

David R Demaso

11

1 reference

30 July 2017

Carl de Moor

12

1 reference

30 July 2017

Blaise Bourgeois

14

1 reference

30 July 2017

publication date

21 May 2010

1 reference

30 July 2017

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

229-237

1 reference

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

10-year research update review: psychiatric problems in children with epilepsy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Optimizing therapy of seizures in children and adolescents with ADHD.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Treatment of attention-deficit/hyperactivity disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Reliability of seizure classification using a semistructured interview

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Semistructured interview for seizure classification: agreement with physicians' diagnoses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Use of Methylphenidate for Attention-Deficit Hyperactivity Disorder in Patients With Epilepsy or Electroencephalographic Abnormalities

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

The epidemiology of epilepsy: the size of the problem

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Prevalence, classification, and severity of epilepsy in children in western Norway.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Phase I clinical trial design in cancer drug development

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Accrual strategies for phase I trials with delayed patient outcome.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Prevalence, classification, and severity of epilepsy and epileptic syndromes in children.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

Prevalence and characteristics of epilepsy in children in northern Sweden

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902631

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

29 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.02.022

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.02.022

Methylphenidate in children with seizures and attention-deficit disorder

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20493783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ADHD and epilepsy in childhood

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20493783

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2010.02.022

1 reference

30 July 2017

1 reference

30 July 2017

1 reference